Integrating Proteomics and Mendelian Randomization to Identify New Therapeutic Targets

Gaetano Santulli1,2,3, Fahimeh Varzideh2, Urna Kansakar1

  • 1Department of Medicine, Division of Cardiology, Wilf Family Cardiovascular Research Institute, Einstein - Mount Sinai Diabetes Research Center (ES-DRC), Einstein Institute for Neuroimmunology and Inflammation (INI), Albert Einstein College of Medicine, New York, NY, USA.

Abstract

No abstract available in PubMed .